While MIs have been most extensively studied in leukemias where menin functions as a co-oncoprotein (47), MIs have also shown efficacy in blocking proliferation of solid tumors, including prostate and hepatocellular carcinoma (36, 48). This evidence concerns the gene MEN1 and leukemia.